|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


,1
* Professional Graduate School of Oriental Medicine, Iksan, Jeonbuk, 570-749, Republic of Korea;
Medical Resources Research Institute, Wonkwang University, 570-749, Republic of Korea; and
Korea Institute of Oriental Medicine, Daejeon, 305-811, Republic of Korea
To whom requests for reprints should be addressed at 1 Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan, Jeonbuk, 570-749, Republic of Korea. E-mail: dgkang{at}wku.ac.kr or host{at}wku.ac.kr
In this study, we aimed to investigate whether an aqueous extract of Buddleja officinalis (ABO) suppresses high-glucose-induced vascular inflammatory processes in the primary cultured human umbilical vein endothelial cells (HUVEC). The high-glucose-induced increase in expression of cell adhesion molecules (CAMs) such as intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial-selectin (E-selectin) was significantly attenuated by pretreatment with ABO in a dose-dependent manner. Enhanced cell adhesion caused by high glucose in co-cultured U937 and HUVEC was also blocked by pretreatment with ABO. Pretreatment with ABO also blocked formation of high-glucose-induced reactive oxygen species (ROS). In addition, ABO suppressed the transcriptional activity of NF-
B and I
B phosphorylation under high-glucose conditions. Pretreatment with N(G)-nitro-L-arginine methyl ester (L-NAME), an endothelial nitric oxide (NO) synthase inhibitor, attenuated the protective action of ABO on high-glucose-induced CAM expression, suggesting a potential role of NO signaling. The present data suggest that ABO could suppress high-glucose-induced vascular inflammatory processes, and ABO may be closely related with the inhibition of ROS and NF-
B activation in HUVEC.
Key Words: Buddleja officinalis adhesion molecules ROS NF-
B HUVEC
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |